Insiders · EYEG

EYEG insider transactions

Eyegate Pharmaceuticals, Inc. (EYEG) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for EYEG

• 1671d
  SEC Form 4 filed by Daniels Eric Joseph

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 1671d
  SEC Form 3 filed by new insider Daniels Eric Joseph

  3 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 1678d
  SEC Form 4: From Stephen covered exercise/tax liability with 250 shares, decreasing direct ownership by 0.36% to 68,292 units

  4 - EYEGATE PHARMACEUTICALS INC (0001372514) (Issuer)
• 1678d
  SEC Form 4: Mann Brenda covered exercise/tax liability with 62 shares, decreasing direct ownership by 0.41% to 15,136 units

  4 - EYEGATE PHARMACEUTICALS INC (0001372514) (Issuer)
• 1678d
  SEC Form 4: Romano Sarah covered exercise/tax liability with 83 shares, decreasing direct ownership by 0.36% to 23,059 units

  4 - EYEGATE PHARMACEUTICALS INC (0001372514) (Issuer)
• 1707d
  SEC Form 4: Romano Sarah covered exercise/tax liability with 83 shares, decreasing direct ownership by 0.36% to 23,142 units

  4 - EYEGATE PHARMACEUTICALS INC (0001372514) (Issuer)
• 1707d
  SEC Form 4: Mann Brenda covered exercise/tax liability with 62 shares, decreasing direct ownership by 0.41% to 15,198 units

  4 - EYEGATE PHARMACEUTICALS INC (0001372514) (Issuer)
• 1707d
  SEC Form 4: From Stephen covered exercise/tax liability with 249 shares, decreasing direct ownership by 0.36% to 68,542 units

  4 - EYEGATE PHARMACEUTICALS INC (0001372514) (Issuer)
• 1739d
  SEC Form 4: From Stephen covered exercise/tax liability with 253 units of Common Stock, decreasing direct ownership by 0.37% to 68,791 units

  4 - EYEGATE PHARMACEUTICALS INC (0001372514) (Issuer)
• 1739d
  SEC Form 4: Romano Sarah covered exercise/tax liability with 84 units of Common Stock, decreasing direct ownership by 0.36% to 23,225 units

  4 - EYEGATE PHARMACEUTICALS INC (0001372514) (Issuer)
• 1739d
  SEC Form 4: Mann Brenda covered exercise/tax liability with 61 units of Common Stock, decreasing direct ownership by 0.40% to 15,260 units

  4 - EYEGATE PHARMACEUTICALS INC (0001372514) (Issuer)
• 1769d
  SEC Form 4: Romano Sarah covered exercise/tax liability with 87 units of Common Stock, decreasing direct ownership by 0.37% to 23,309 units

  4 - EYEGATE PHARMACEUTICALS INC (0001372514) (Issuer)
• 1769d
  SEC Form 4: Mann Brenda covered exercise/tax liability with 63 units of Common Stock, decreasing direct ownership by 0.41% to 15,321 units

  4 - EYEGATE PHARMACEUTICALS INC (0001372514) (Issuer)
• 1769d
  SEC Form 4: MANZO MICHAEL P. covered exercise/tax liability with 65 units of Common Stock, decreasing direct ownership by 0.42% to 15,378 units

  4 - EYEGATE PHARMACEUTICALS INC (0001372514) (Issuer)
• 1769d
  SEC Form 4: FROM STEPHEN covered exercise/tax liability with 261 units of Common Stock, decreasing direct ownership by 0.38% to 69,044 units

  4 - EYEGATE PHARMACEUTICALS INC (0001372514) (Issuer)
• 1771d
  SEC Form 3 filed by Strem Brian M.

  3 - EYEGATE PHARMACEUTICALS INC (0001372514) (Issuer)
• 1775d
  SEC Form 4: ARMISTICE CAPITAL, LLC sold $14,546,264 worth of Common Stock (3,153,138 units at $4.61) and converted options into 852,500 units of Common Stock

  4 - EYEGATE PHARMACEUTICALS INC (0001372514) (Issuer)
• 1798d
  SEC Form 4: FROM STEPHEN covered exercise/tax liability with 877 units of Common Stock, decreasing direct ownership by 1% to 69,305 units

  4 - EYEGATE PHARMACEUTICALS INC (0001372514) (Issuer)
• 1798d
  SEC Form 4: Mann Brenda covered exercise/tax liability with 154 units of Common Stock, decreasing direct ownership by 0.99% to 15,384 units

  4 - EYEGATE PHARMACEUTICALS INC (0001372514) (Issuer)
• 1798d
  SEC Form 4: MANZO MICHAEL P. covered exercise/tax liability with 160 units of Common Stock, decreasing direct ownership by 1% to 15,443 units

  4 - EYEGATE PHARMACEUTICALS INC (0001372514) (Issuer)
• 1798d
  SEC Form 4: Romano Sarah covered exercise/tax liability with 180 units of Common Stock, decreasing direct ownership by 0.76% to 23,396 units

  4 - EYEGATE PHARMACEUTICALS INC (0001372514) (Issuer)
• 1827d
  SEC Form 4 filed by Eyegate Pharmaceuticals, Inc.

  4 - EYEGATE PHARMACEUTICALS INC (0001372514) (Issuer)
• 1827d
  SEC Form 4: FROM STEPHEN covered exercise/tax liability with 878 units of Common Stock, decreasing direct ownership by 1% to 70,182 units

  4 - EYEGATE PHARMACEUTICALS INC (0001372514) (Issuer)
• 1827d
  SEC Form 4 filed by Eyegate Pharmaceuticals, Inc.

  4 - EYEGATE PHARMACEUTICALS INC (0001372514) (Issuer)
• 1827d
  SEC Form 4 filed by Eyegate Pharmaceuticals, Inc.

  4 - EYEGATE PHARMACEUTICALS INC (0001372514) (Issuer)
• 1860d
  SEC Form 4: MANZO MICHAEL P. disposed of $653 worth of Common Stock (158 units at $4.13), decreasing direct ownership by 0.99% to 15,758 units

  4 - EYEGATE PHARMACEUTICALS INC (0001372514) (Issuer)
• 1860d
  SEC Form 4: Romano Sarah disposed of $731 worth of Common Stock (177 units at $4.13), decreasing direct ownership by 0.74% to 23,756 units

  4 - EYEGATE PHARMACEUTICALS INC (0001372514) (Issuer)
• 1860d
  SEC Form 4: FROM STEPHEN disposed of $3,672 worth of Common Stock (889 units at $4.13), decreasing direct ownership by 1% to 71,060 units

  4 - EYEGATE PHARMACEUTICALS INC (0001372514) (Issuer)
• 1860d
  SEC Form 4: Mann Brenda disposed of $789 worth of Common Stock (191 units at $4.13), decreasing direct ownership by 1% to 15,693 units

  4 - EYEGATE PHARMACEUTICALS INC (0001372514) (Issuer)
• 1874d
  SEC Form 4 filed by Shapiro Aron

  4 - EYEGATE PHARMACEUTICALS INC (0001372514) (Issuer)
• 1874d
  SEC Form 4 filed by Gayron Kenneth L

  4 - EYEGATE PHARMACEUTICALS INC (0001372514) (Issuer)
• 1881d
  SEC Form 3 filed by Gayron Kenneth L

  3 - EYEGATE PHARMACEUTICALS INC (0001372514) (Issuer)
• 1883d
  SEC Form 3 filed by Aron Shapiro

  3 - EYEGATE PHARMACEUTICALS INC (0001372514) (Issuer)
• 1886d
  SEC Form 4: Brenda Mann disposed of $948 worth of Common Stock (192 units at $4.94), decreasing direct ownership by 1% to 15,884 units

  4 - EYEGATE PHARMACEUTICALS INC (0001372514) (Issuer)
• 1886d
  SEC Form 4: P. Michael Manzo disposed of $958 worth of Common Stock (194 units at $4.94), decreasing direct ownership by 1% to 15,916 units

  4 - EYEGATE PHARMACEUTICALS INC (0001372514) (Issuer)
• 1886d
  SEC Form 4: Sarah Romano disposed of $889 worth of Common Stock (180 units at $4.94), decreasing direct ownership by 0.75% to 23,933 units

  4 - EYEGATE PHARMACEUTICALS INC (0001372514) (Issuer)
• 1886d
  SEC Form 4: Stephen From disposed of $4,441 worth of Common Stock (899 units at $4.94), decreasing direct ownership by 1% to 71,949 units

  4 - EYEGATE PHARMACEUTICALS INC (0001372514) (Issuer)
• 1921d
  SEC Form 4: Stephen From disposed of $4,903 worth of Common Stock (898 units at $5.46), decreasing direct ownership by 1% to 72,848 units

  4 - EYEGATE PHARMACEUTICALS INC (0001372514) (Issuer)
• 1921d
  SEC Form 4: P. Michael Manzo disposed of $1,048 worth of Common Stock (192 units at $5.46), decreasing direct ownership by 1% to 16,110 units

  4 - EYEGATE PHARMACEUTICALS INC (0001372514) (Issuer)
• 1921d
  SEC Form 4: Sarah Romano disposed of $1,190 worth of Common Stock (218 units at $5.46), decreasing direct ownership by 0.90% to 24,113 units

  4 - EYEGATE PHARMACEUTICALS INC (0001372514) (Issuer)
• 1921d
  SEC Form 4: Brenda Mann disposed of $1,048 worth of Common Stock (192 units at $5.46), decreasing direct ownership by 1% to 16,076 units

  4 - EYEGATE PHARMACEUTICALS INC (0001372514) (Issuer)
• 1951d
  SEC Form 4: P. Michael Manzo disposed of $6,277 worth of Common Stock (990 units at $6.34), decreasing ownership by 6% to 16,302 units

  4 - EYEGATE PHARMACEUTICALS INC (0001372514) (Issuer)
• 1951d
  SEC Form 4: Stephen From disposed of $22,456 worth of Common Stock (3,542 units at $6.34), decreasing ownership by 5% to 73,746 units

  4 - EYEGATE PHARMACEUTICALS INC (0001372514) (Issuer)
• 1951d
  SEC Form 4: Brenda Mann disposed of $6,264 worth of Common Stock (988 units at $6.34), decreasing ownership by 6% to 16,268 units

  4 - EYEGATE PHARMACEUTICALS INC (0001372514) (Issuer)
• 1951d
  SEC Form 4 filed by Praveen Tyle

  4 - EYEGATE PHARMACEUTICALS INC (0001372514) (Issuer)
• 1951d
  SEC Form 4: Sarah Romano disposed of $8,128 worth of Common Stock (1,282 units at $6.34), decreasing ownership by 5% to 24,331 units

  4 - EYEGATE PHARMACEUTICALS INC (0001372514) (Issuer)
• 1951d
  SEC Form 4 filed by Thomas Hancock

  4 - EYEGATE PHARMACEUTICALS INC (0001372514) (Issuer)
• 1951d
  SEC Form 4 filed by G Paul Chaney

  4 - EYEGATE PHARMACEUTICALS INC (0001372514) (Issuer)
• 1951d
  SEC Form 4 filed by Bernard Malfroy-Camine

  4 - EYEGATE PHARMACEUTICALS INC (0001372514) (Issuer)
• 1951d
  SEC Form 4 filed by Morton Goldberg

  4 - EYEGATE PHARMACEUTICALS INC (0001372514) (Issuer)
• 1951d
  SEC Form 4 filed by Franz Obermayr

  4 - EYEGATE PHARMACEUTICALS INC (0001372514) (Issuer)
• 1951d
  SEC Form 3: Franz Obermayr claimed ownership of 101,613 units of Common Stock

  3 - EYEGATE PHARMACEUTICALS INC (0001372514) (Issuer)